We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.
The cookies that are categorised as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ...
Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.
Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.
Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Advertisement cookies are used to provide visitors with customised advertisements based on the pages you visited previously and to analyse the effectiveness of the ad campaigns.
Associate Professor in Cardiometabolic in the Diabetes and Vascular Research Centre, University of Exeter Medical School
Prof in Cardiometabolic Health
Chair of British Medical Association Board of Science and Academic Staff Committee
Co-Clinical and Academic Lead of the Healthcare for Older People department
University of Exeter Medical School, UK
David Strain is an Associate Professor in Cardiometabolic at the Diabetes and Vascular Research Centre at the University of Exeter Medical School, with expertise in microvascular structure and function. Clinically, he runs a community service for older adults with diabetes and/or cardiovascular disease and works as an in-patient consultant.
His main focus is the health of older adults with diabetes; ensuring the right patient gets the right treatment. This includes research exploring the mechanism that some medications, specifically the SGLT-2 inhibitors and GLP-1 analogues, give benefits to people with diabetes, heart disease and renal failure beyond their effect on sugar and blood pressure. The hope is we can identify those who would benefit most before arising. He has performed the only study to date demonstrating the feasibility of individualizing targets for older adults across Europe. As a result, he led the stakeholders group that produced the UK guidelines for the management of older adults with type 2 diabetes that informed the new UK NICE guidance and modification to the Quality Outcome Framework.
Since April 2019, he has also been running a COVID service as clinical lead in COVID for Exeter, been involved in the national Long COVID taskforce, and established research into the underlying causes and potential cures.
Are you ready to transform your skills and unlock your full potential? Now is the time to elevate your training.
Join Now